Newish Biotech (wuxi) Co., Ltd.
Clinical trials sponsored by Newish Biotech (wuxi) Co., Ltd., explained in plain language.
-
Experimental shot aims to reverse HPV-Linked cervical precancer
Disease control Not yet recruitingThis study tests an experimental biologic, NWRD09, in women aged 18 to 65 with HPV16-positive cervical high-grade squamous intraepithelial lesions (HSIL), a precancerous condition. Participants receive four intramuscular injections over 12 weeks. The main goal is to see if the tr…
Phase: PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New shot aims to clear stubborn HPV infection in women
Disease control Not yet recruitingThis early-stage study tests a new drug called NWRD09 in 78 women aged 18-60 who have had a persistent HPV16 infection for at least 6 months. The goal is to see if the injection is safe and can help the body clear the virus. Participants will receive either the drug or a placebo,…
Phase: PHASE1, PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC